Trials / Completed
CompletedNCT03526419
Exparel PK and Breast Milk Excretion
Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine After TAP Block in Patients Undergoing Cesarean Section Delivery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Investigate the pharmacokinetics of Liposomal Bupivacaine and its excretion in breast milk in patients undergoing TAP block after their scheduled C -section delivery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine liposome | blood and milk samples will be obtained from those subjects after TAP block |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2018-05-16
- Last updated
- 2019-09-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03526419. Inclusion in this directory is not an endorsement.